LeMaitre Vascular - 19 Year Stock Price History | LMAT
- The all-time high LeMaitre Vascular stock closing price was 107.45 on November 22, 2024.
- The LeMaitre Vascular 52-week high stock price is 109.58, which is 37.4% above the current share price.
- The LeMaitre Vascular 52-week low stock price is 71.42, which is 10.5% below the current share price.
- The average LeMaitre Vascular stock price for the last 52 weeks is 89.83.
LeMaitre Vascular Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 87.5249 | 91.0257 | 103.4950 | 77.7023 | 79.7700 | -13.00% |
2024 | 79.0773 | 55.9865 | 107.4460 | 53.3110 | 91.6925 | 63.63% |
2023 | 54.3200 | 44.3955 | 66.9937 | 43.7115 | 56.0358 | 24.60% |
2022 | 45.2929 | 49.7960 | 54.4342 | 37.8556 | 44.9721 | -7.40% |
2021 | 50.1260 | 38.5253 | 60.9869 | 38.5253 | 48.5680 | 25.10% |
2020 | 29.2687 | 33.8852 | 39.5605 | 19.9717 | 38.8224 | 14.09% |
2019 | 28.5137 | 21.8952 | 34.2732 | 21.0153 | 34.0271 | 53.76% |
2018 | 31.1032 | 28.8885 | 38.1510 | 20.6034 | 22.1293 | -25.13% |
2017 | 27.9311 | 23.2497 | 36.2660 | 20.1811 | 29.5569 | 26.58% |
2016 | 15.9075 | 14.4246 | 23.4616 | 11.3974 | 23.3510 | 48.46% |
2015 | 10.2383 | 7.0267 | 16.2026 | 6.5504 | 15.7285 | 128.81% |
2014 | 6.7656 | 7.0579 | 7.4670 | 5.9012 | 6.8739 | -2.73% |
2013 | 5.8985 | 4.9932 | 7.6049 | 4.9932 | 7.0667 | 42.02% |
2012 | 5.0709 | 4.8916 | 5.6347 | 4.2805 | 4.9758 | -1.37% |
2011 | 5.6031 | 5.8413 | 6.3496 | 4.4996 | 5.0450 | -11.46% |
2010 | 4.8355 | 4.1916 | 6.1275 | 3.7203 | 5.6983 | 35.40% |
2009 | 2.7768 | 1.8012 | 4.2085 | 1.6076 | 4.2085 | 116.64% |
2008 | 3.0232 | 5.0502 | 5.6478 | 1.5655 | 1.9426 | -62.77% |
2007 | 5.4532 | 5.0922 | 6.4390 | 4.6798 | 5.2185 | 3.33% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $1.802B | $0.220B |
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $215.166B | 25.24 |
Boston Scientific (BSX) | United States | $153.330B | 38.39 |
Stryker (SYK) | United States | $148.630B | 31.08 |
EssilorLuxottica (ESLOY) | France | $131.070B | 0.00 |
Medtronic (MDT) | Ireland | $114.929B | 16.29 |
Lonza Group Ag (LZAGY) | Switzerland | $49.764B | 0.00 |
Haleon (HLN) | United Kingdom | $43.126B | 24.62 |
ResMed (RMD) | United States | $37.818B | 28.41 |
GE HealthCare Technologies (GEHC) | United States | $34.781B | 16.51 |
Agilent Technologies (A) | United States | $32.381B | 21.11 |
Terumo (TRUMY) | Japan | $23.911B | 31.06 |
Koninklijke Philips (PHG) | Netherlands | $23.688B | 16.62 |
Insulet (PODD) | United States | $20.003B | 78.52 |
Zimmer Biomet Holdings (ZBH) | United States | $18.437B | 11.84 |
Baxter (BAX) | United States | $14.251B | 10.64 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.214B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
Demant (WILYY) | Denmark | $8.633B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.705B | 23.33 |
Lantheus Holdings (LNTH) | United States | $4.855B | 12.25 |
Prestige Consumer Healthcare (PBH) | United States | $3.744B | 16.73 |
Perrigo (PRGO) | Ireland | $3.706B | 9.39 |
Haemonetics (HAE) | United States | $3.485B | 15.88 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.307B | 27.48 |
ICU Medical (ICUI) | United States | $3.014B | 22.23 |
QuidelOrtho (QDEL) | United States | $1.721B | 11.84 |
AtriCure (ATRC) | United States | $1.449B | 0.00 |
Acuren (TIC) | United States | $1.408B | 0.00 |
AdaptHealth (AHCO) | United States | $1.244B | 12.63 |
Phibro Animal Health (PAHC) | United States | $1.192B | 15.24 |
Green Thumb Industries (GTBIF) | United States | $1.190B | 26.76 |
Neogen (NEOG) | United States | $1.029B | 13.17 |
BioLife Solutions (BLFS) | United States | $0.996B | 0.00 |
InMode (INMD) | Israel | $0.878B | 8.85 |
Kestra Medical Technologies (KMTS) | United States | $0.816B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.625B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.619B | 0.00 |
Owens & Minor (OMI) | United States | $0.599B | 4.97 |
Evolus (EOLS) | United States | $0.593B | 0.00 |
CeriBell (CBLL) | United States | $0.563B | 0.00 |
Valneva SE (VALN) | France | $0.557B | 0.00 |
Surmodics (SRDX) | United States | $0.432B | 0.00 |
SNDL (SNDL) | Canada | $0.405B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.336B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.315B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.314B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.298B | 10.97 |
Quanterix (QTRX) | United States | $0.268B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.267B | 0.00 |
Cerus (CERS) | United States | $0.260B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.257B | 21.63 |
Aurora Cannabis (ACB) | Canada | $0.255B | 75.50 |
OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
ZimVie (ZIMV) | United States | $0.235B | 10.68 |
Sanara MedTech (SMTI) | United States | $0.234B | 0.00 |
Brainsway (BWAY) | Israel | $0.228B | 60.45 |
Biote (BTMD) | United States | $0.220B | 6.18 |
Canopy Growth (CGC) | Canada | $0.200B | 0.00 |
High Tide (HITI) | Canada | $0.199B | 0.00 |
Omeros (OMER) | United States | $0.197B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.195B | 0.00 |
Organigram Global (OGI) | Canada | $0.194B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.180B | 14.69 |
TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
Vireo Growth (VREOF) | United States | $0.149B | 0.00 |
Exagen (XGN) | United States | $0.149B | 0.00 |
FitLife Brands (FTLF) | United States | $0.120B | 14.73 |
TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
Jin Medical (ZJYL) | China | $0.103B | 0.00 |
Fonar (FONR) | United States | $0.099B | 12.80 |
MacroGenics (MGNX) | United States | $0.093B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.091B | 0.00 |
Veru (VERU) | United States | $0.087B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
Apyx Medical (APYX) | United States | $0.085B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.076B | 0.00 |
Zynex (ZYXI) | United States | $0.070B | 0.00 |
Agape ATP (ATPC) | $0.065B | 0.00 | |
Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
ImmuCell (ICCC) | United States | $0.060B | 0.00 |
Safety Shot (SHOT) | United States | $0.055B | 0.00 |
United-Guardian (UG) | United States | $0.042B | 14.52 |
Nephros (NEPH) | United States | $0.039B | 52.07 |
Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
Modular Medical (MODD) | United States | $0.037B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
INLIF (INLF) | $0.015B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
Flora Growth (FLGC) | United States | $0.014B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
Senestech (SNES) | United States | $0.010B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
Sharps Technology (STSS) | United States | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
InterCure (INCR) | Israel | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |